Core Viewpoint - Tianyi Medical (301097) experienced a significant decline in stock price, closing at 58.24 yuan on November 19, 2025, down 5.35% from the previous day [1] Group 1: Stock Performance and Trading Data - On November 19, 2025, the trading volume was 17,500 hands, with a total transaction amount of 102 million yuan [1] - The net outflow of main funds was 2.25% of the total transaction amount, while retail investors saw a net inflow of 5.26% [1] - Over the past five days, the stock has shown fluctuating performance, with a notable drop on November 19 and a previous increase on November 18 [1][2] Group 2: Financing and Margin Trading - On November 19, 2025, the financing balance was 63.63 million yuan, with a net financing purchase of 10.18 million yuan [2] - The stock has not seen any short selling activity, with no shares sold or repaid [2] Group 3: Company Financials and Industry Comparison - For the first three quarters of 2025, Tianyi Medical reported a main revenue of 387 million yuan, a year-on-year increase of 24.14% [4] - The net profit for the same period was 20.09 million yuan, reflecting a substantial year-on-year increase of 216.81% [4] - The company’s total market capitalization is 3.418 billion yuan, significantly lower than the industry average of 11.278 billion yuan [4] - Key financial ratios indicate that Tianyi Medical has a price-to-earnings ratio of 127.57 and a gross margin of 38.39%, both of which are below industry averages [4]
天益医疗（301097）11月19日主力资金净卖出230.13万元